166 related articles for article (PubMed ID: 30840795)
1. Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men.
Kim JH; Moon HS; Kim KS; Hwang HS; Ryu JS; Park SY
Korean J Parasitol; 2019 Feb; 57(1):21-25. PubMed ID: 30840795
[TBL] [Abstract][Full Text] [Related]
2. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.
Saleh NE; Alhusseiny SM; El-Zayady WM; Aboelnaga EM; El-Beshbishi WN; Saleh YM; Abou-ElWafa HS; El-Beshbishi SN
Parasitol Res; 2021 Apr; 120(4):1379-1388. PubMed ID: 33159459
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis.
Kim SS; Kim JH; Han IH; Ahn MH; Ryu JS
Korean J Parasitol; 2016 Apr; 54(2):123-32. PubMed ID: 27180569
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Trichomonas vaginalis by PCR in men attending a primary care urology clinic in South Korea.
Seo JH; Yang HW; Joo SY; Song SM; Lee YR; Ryu JS; Yoo ES; Lee WK; Kong HH; Lee SE; Lee WJ; Goo YK; Chung DI; Hong Y
Korean J Parasitol; 2014 Oct; 52(5):551-5. PubMed ID: 25352707
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia.
Han IH; Kim JH; Ryu JS
Parasites Hosts Dis; 2023 Feb; 61(1):2-14. PubMed ID: 37170459
[TBL] [Abstract][Full Text] [Related]
6. Molecular Examination of
Kamarkhani Z; Rafiei-Sefiddashti R; Haghighi L; Badirzadeh A; Hadighi R
Ethiop J Health Sci; 2021 Mar; 31(2):237-240. PubMed ID: 34158774
[TBL] [Abstract][Full Text] [Related]
7. Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia.
Iqbal J; Al-Rashed J; Kehinde EO
BMC Infect Dis; 2016 Sep; 16(1):506. PubMed ID: 27660027
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.
Marous M; Huang WY; Rabkin CS; Hayes RB; Alderete JF; Rosner B; Grubb RL; Winter AC; Sutcliffe S
Cancer Causes Control; 2017 Aug; 28(8):889-898. PubMed ID: 28669054
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea.
Kim SR; Kim JH; Gu NY; Kim YS; Hong YC; Ryu JS
Korean J Parasitol; 2016 Apr; 54(2):187-90. PubMed ID: 27180577
[TBL] [Abstract][Full Text] [Related]
10. Persistence of Trichomonas vaginalis serostatus in men over time.
Sutcliffe S; Alderete JF; Neace C; Joyce PA; Gaydos CA; Huth JI; Mucci LA; Signorello LB
Cancer Causes Control; 2015 Oct; 26(10):1461-6. PubMed ID: 26223890
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
[TBL] [Abstract][Full Text] [Related]
12. High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue.
Mitteregger D; Aberle SW; Makristathis A; Walochnik J; Brozek W; Marberger M; Kramer G
Med Microbiol Immunol; 2012 Feb; 201(1):113-6. PubMed ID: 21660495
[TBL] [Abstract][Full Text] [Related]
13. Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.
Langston ME; Bhalla A; Alderete JF; Nevin RL; Pakpahan R; Hansen J; Elliott D; De Marzo AM; Gaydos CA; Isaacs WB; Nelson WG; Sokoll LJ; Zenilman JM; Platz EA; Sutcliffe S
Prostate; 2019 Oct; 79(14):1622-1628. PubMed ID: 31376187
[TBL] [Abstract][Full Text] [Related]
14. Comparison between mixed lysate antigen and α-actinin antigen in ELISA for serodiagnosis of trichomoniasis.
Kim SR; Kim JH; Park SJ; Lee HY; Kim YS; Kim YM; Hong YC; Ryu JS
Parasitol Int; 2015 Oct; 64(5):405-7. PubMed ID: 26072305
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Trichomonas vaginalis in Women Visiting 2 Obstetrics and Gynecology Clinics in Daegu, South Korea.
Goo YK; Shin WS; Yang HW; Joo SY; Song SM; Ryu JS; Lee WM; Kong HH; Lee WK; Lee SE; Lee WJ; Chung DI; Hong Y
Korean J Parasitol; 2016 Feb; 54(1):75-80. PubMed ID: 26951983
[TBL] [Abstract][Full Text] [Related]
16. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
17. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer.
Vicier C; Werner L; Chipman J; Harshman LC; Patil DH; Fichorova RN; Rider JR; Sanda MG; Mucci LA; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):32-37. PubMed ID: 30348512
[TBL] [Abstract][Full Text] [Related]
18. Inflammation driven tumor-like signaling in prostatic epithelial cells by sexually transmitted Trichomonas vaginalis.
Kushwaha B; Devi A; Maikhuri JP; Rajender S; Gupta G
Int J Urol; 2021 Feb; 28(2):225-240. PubMed ID: 33251708
[TBL] [Abstract][Full Text] [Related]
19. IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages.
Han IH; Song HO; Ryu JS
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008126. PubMed ID: 32196489
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.
Chen YC; Huang YL; Platz EA; Alderete JF; Zheng L; Rider JR; Kraft P; Giovannucci E; Sutcliffe S
Cancer Causes Control; 2013 Jan; 24(1):175-80. PubMed ID: 23179660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
